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Summary 
Neonatal thymectomy (NTx),  especially around day 3 after birth, causes various organ-specific 
autoimmune  diseases in mice.  This report shows  that:  (a)  T  cells expressing the interleukin  2 
receptor cx chains  (CD25)  ontogenically begin to appear in the normal periphery immediately 
after day 3,  rapidly increasing within  2  wk to nearly adult levels (~10%  of CD3 + cells,  espe- 
cially ofCD4 + cells); (b) NTx on day 3  eliminates CD25 + T  cells from the periphery for sev- 
eral days; inoculation immediately after NTx of CD25 + splenic T  cells from syngeneic non-Tx 
adult mice prevents autoimmune development,  whereas inoculation  of CD25-  T  cells even at 
a  larger dose  does  not;  and  furthermore,  (c) similar autoimmune  diseases  can be produced  in 
adult athymic nu/nu  mice by inoculating either spleen cell suspensions from 3-d-old euthymic 
nu/+  mice  or CD25 +  cell-depleted  spleen  cell suspensions  from older,  even  1-yr-old,  nu/+ 
mice.  The CD25-  populations  from neonates  or adults are also similar in the profile of cyto- 
kine formation.  These results,  taken together,  indicate  that one aspect of peripheral  self-toler- 
ance is maintained by CD25 + T  ceils that sustain potentially pathogenic self-reactive T  ceils in 
a CD25-  dormant state; the thymic production  of the former is developmentally programmed 
to begin on day 3  after birth in mice. Thus,  NTx on day 3  can, at least transiently,  eliminate/ 
reduce  the  autoimnmne-preventive  CD25 +  T  cells,  thereby leading  to activation  of the  self- 
reactive T  ceils that have been produced before NTx. 
A 
lthough  the etiology of spontaneous  autoimmune  dis- 
eases is largely unknown  at present,  autoimmune  dis- 
ease  may  develop  as  a  consequence  of altered  control  of 
potentially  pathogenic  self-reactive  lymphocytes  that  rec- 
ognize  antigenically  normal  self-constituents  (1).  Indeed, 
simple manipulation of the thymus/T cells, without exoge- 
nous  immunization  with  self-antigens  in  potent  adjuvant, 
can  cause  autoimmune  disease  in  normal  animals  (for re- 
views  see  references  2  and  3).  For  example,  neonatal 
thymectomy (NTx)l,  especially between days 2  and 4  after 
birth,  of selected strains  of normal mice, produces  various 
autoimmune  diseases,  such  as  hemolytic  anemia,  thyroidi- 
tis,  gastritis,  oophoritis,  or  orchitis  (4-11).  In  this  report, 
V  Abbreviations used in this paper: as, antisense; NTx, neonatal thymectomy; 
RT, reverse transcriptase, s, sense; Tx, thymectomy. 
The results of this work were reported at the annual meeting of the Japa- 
nese Society of Immunology in November 1993 and at the 9th Interna- 
tional Congress of Immunology in July 1995. 
we  investigate  the  mechanism  by which  NTx  causes  au- 
toimmune  disease in normal mice,  and  thereby attempt to 
show  how  the  normal  immune  system  developmentally 
controls potentially pathogenic self-reactive T  cells. 
Based on various T  cell abnormalities in NTx mice, sev- 
eral possible mechanisms have been proposed on the NTx- 
induced  autoimmune  disease,  such  as:  insufficient  clonal 
deletion  in neonatal period and the inability of NTx  mice 
to eliminate leaked self-reactive T  cell clones that would be 
deleted in normal non-Tx mice upon recirculation through 
the thymus (12-15);  reduction/elimination  of an immuno- 
regulatory  T  cell  population  by NTx  (16);  NTx-induced 
alteration  of lymphocyte  population  kinetics  towards  ex- 
pansion  of self-reactive T  cells  (17,  18);  or infection  with 
autoimmune-eliciting  viruses due  to NTx-induced  immu- 
nodeficiency  (19).  It remains  obscure,  however,  which  of 
these  plausible  mechanisms  is  the  primary  one  by  which 
NTx triggers autoimmune disease. To determine a particu- 
lar NTx-induced  T  cell abnormality as the primary trigger- 
ing  event  of the  autoimmune  development,  correction  of 
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mice, and, further,  the same autoimmune  disease must be 
produced by introducing the abnormality itself into normal 
mice direcdy, not indirectly by NTx. 
We and others  (20-23)  have previously shown that au- 
toimmune  diseases,  including  those  produced  by  NTx, 
spontaneously developed dn normal rodents when  CD5 high 
or CD45RB/C l~  cells v~ere  eliminated from  the  periph- 
eral CD4 + population; rer  of the respective elim- 
inated  population  prevented  autoimmune  development. 
Assuming that CD4 +  T  ce~  capable of preventing NTx- 
autoimmune disease may well be CD5hig  h and CD45RB l~ 
and  begin  to  appear in  the  periphery around  day  3  after 
birth in normal ontogeny, w.e have searched for a T  cell sur- 
face molecule that is more specific than CD5 or CD45RB/C 
in delineating such an autoimmune-preventive CD4 § pop- 
ulation.  This  search  revealed  the  IL-2  receptor  c~  chain 
(CD25)  molecule as a  candidate, since CD25  is expressed 
on a subpopulation ofCD5 hi~ and CD45RB l~  CD4 + cells 
(24).  In this report, we show that CD25-expressing T  cells 
ontogenically begin to appear in the periphery immediately 
after day 3,  and NTx-induced autoimmune  disease can be 
prevented by inoculating CD25 + splenic T  cells from non- 
Tx normal mice; furthermore, similar autoimmune diseases 
can be produced in adult mice by directly eliminating pe- 
ripheral CD25 + T  cells. Our.results indicate that self-toler- 
ance is developmentally established not only by clonal de- 
letion but also by T  cell-mediated control of self-reactive 
T  cells. 
Materials and Methods 
Mice.  BALB/c mice, BALB/c  nu/nu mice of 6  wk of age, 
and BALB/c nu/+ mice of 8 wk of age were purchased from Ja- 
pan SLC, Inc.  (Shizuoka, Japan).  They were maintained in the 
animal facility of the Institute of Physical and Chemical kesearch 
(R.IKEN). To obtain newborn BALB/c mice, mice were mated 
in our facility. 
NTx.  Tx was performed on day 3 after birth (the day of  birth 
as day 0). Mice were anesthesized by keeping them in crushed ice 
for 2-3 min, and the thymus was removed en bloc under a dis- 
secting microscope with a cottonhead toothpick (25).  Sham Tx 
was performed by cutting the  sternum without removal of the 
thymus. The wound was sutured and the mice were kept at 30~ 
overnight and then returned to their mothers. 
Preparation of T Cell Subpopulations.  Lymphocyte  suspensions 
(5 ￿  107) prepared from spleens and lymph nodes (inguinal, axil- 
lary, brachial, and mesenteric) were incubated in  12  ￿  75-mm 
glass tubes (Coming, Coming, NY) with 100 ~1 of 1 : 10-diluted 
ascites  of anti-CD25  (7D4,  rat  IgM)  (26),  anti-L3T4  (CD4) 
(GK1.5, rat IgG2b)  (27),  or anti-Lyt-2.2 (CD8)  (mouse IgG2a) 
(28)  for  45  rain  on  ice.  They  were  washed  once  with  HBSS 
(GIBCO BRL, Gaithersburg, MD) and incubated with 1.0 ml of 
nontoxic rabbit serum (GIBCO BR.L)  1 : 5-diluted with Medium 
199  (GIBCO BR.L) for 30 rain in a 37~  water bath with occa- 
sional vigorous shakings;  100  Ixg of DNase  I  (Sigma Chemical 
Co., St. Louis, MO) was added for the last 5 min of the incuba- 
tion. The suspensions were then washed twice with HBSS, and 
injected intraperitoneally into NTx mice 1 wk after NTx or in- 
travenously into 6-8-wk-old female nu/nu mice (24). To remove 
CD4 § cells completely after anti-L3T4 +  C treatment, the treated 
cells were  incubated for  1 h  at 4~  on plastic dishes precoated 
overnight  with  affinity-purified anti-rat  IgG  (Cappel-Organon 
Teknika, West  Chester,  PA),  and  nonadherent  cells were  col- 
lected (24). Less than 1% oflymphocytes after the anti-Lyt-2.2 + 
C, anti-L3T4  +  C  and subsequent panning treatment, or anti- 
CD25  (7D4) and anti-Lyt-2.2 +  C  treatment, were positive for 
FITC-rat anti-Lyt-2 (CDS)  (53-6.7)  (29),  FITC-F(ab')2 anti-rat 
IgG (Jackson ImmunoR.esearch, West Grove, PA), or anti-CD25 
(PC61) (30) plus FITC-anti-rat IgG staining, respectively. 
For enrichment ofCD25 + T  cells, spleen and lymph node cell 
suspensions were first enriched for CD4 § cells by incubating the 
cells with the mixture of culture supematants ofJllD  (rat IgM) 
(31)  and  anti-CD8  (rat  IgG)  (29),  and  then  panned  on  plastic 
dishes  precoated  overnight  with  affinity-purified anti-rat  IgG 
(Cappel-Organon Teknika). The CD4 § cells (>90% pure) were 
then panned on plastic dishes precoated overnight with purified 
7D4 mAb (100 t.tg/ml), and the adherent cells were collected by 
scraping with a rubber policeman. They were 50--60% pure for 
CD25 + cells. To obtain a pure CD4 + CD25 + or CD4 + CD25- 
population for reverse transcriptase  (RT)-PCR analysis (see below), 
cells stained with PE-anti-CD4 and FITC-anti-CD25 were sorted 
by a FACStar  |  flow cytometer with Consort 30 program (Becton 
Dickinson & Co., Mountain View, CA) as previously described (32). 
Flow Cytometric Analysis.  106  cells  were  stained with  FITC- 
anti-CD3  (145-2Cll)  (33)  and  biotinylated anti-CD25  (7D4), 
purchased from PharMingen (San Diego, CA), and PE-streptavi- 
din  (Biomeda,  Foster City,  CA)  as the  secondary reagent,  and 
then analyzed by a FACScan  |  flow cytometer (Becton Dickinson 
& Co.), as previously described (24). 
ELISA for Detecting Serum Autoantibodies.  A  detailed descrip- 
tion  of the  ELISA (using alkaline phosphatase--conjugated sec- 
ondary antibody and p-nitrophenyl disodium hexahydrate as the 
substrate)  used  to  detect  autoantibodies  against  gastric  parietal 
cells was given earlier (34). 
Histology and Criteria  for Grading Autoimmune Disease.  Tissues 
and organs (thyroid, lung, pancreas, stomach, adrenal gland, kid- 
ney, ovaries, or testes) were fixed in 10% formalin and processed 
for hematoxylin and eosin staining. Gastritis was graded from 0 to 
2+  depending on macroscopic and histological severity: 0  =  the 
gastric mucosa was histologically  intact; 1 +  =  gastritis with histo- 
logically evident destruction of parietal cells and cellular infiltra- 
tion of the gastric mucosa; and 2+  =  severe destruction of the 
gastric mucosa accompanying the formation of giant rugae due to 
compensatory hyperplasia of mucous-secreting cells (see reference 
20 for the giant rugae) (24). 
RT-PCR.  Total cellular ILNA was isolated from l0  s FACS  | 
sorted  cells  by  modification  of the  guanidium  isothiocyanate 
method  (35).  RNA  was  converted  to  eDNA  with  oligo-dT 
primer and Moloney murine leukemia virus R.T (Toyobo, Osaka, 
Japan). The eDNA was preamplified with random 15-nucleotide 
primers; each aliquoted eDNA sample was then amplified with 
specific  primers  (see  below)  in  Falcon  Microtest  III  flexible 
U-bottomed,  96-well assay plates  (Becton Dickinson Labware, 
Oxnard,  CA)  on  a PTC-100  programmable thermal controller 
(MJ  Research  Inc.,  Watertown,  MA).  PClk  conditions  were 
strictly defined for  each  primer pair.  The  following sequences 
(sense  [s]  and  antisense  [as]) were  synthesized and  used  as  the 
primers:  HPR.T  (s)  5'-GATACAGGCCAGACTTGTTGG-3', 
(as) 5'-GAGGGTAGGCTGGCCTATAGG-3'; CD4 (s) 5'-AG- 
GTCAAGATGGACTCCAGG-3', (as) 5'-GGCTCTTCTGCA- 
TCCGGTGG-3'; CD25  (s) 5'-CAGACATGCAGAAGCCAA- 
CAC-3', (as) 5'-GGTGAGCCCGCTCAGGAGGA-3'; IL-2, (s) 
388  Developmental Control of Self-reactive T Cells 5'-AAGATGAACTTGGACCTCTGCGG-3', (as) 5'-CCTTAT- 
GTGTTGTAAGCAGGAGG-3'; IL-4 (s) 5'-ATGGGTCTCAA- 
CCCCCAGCTAGT-3', (as) 5'-GCTCTTTAGGCTTTCCAG- 
GAAGTC-3'; 1L-10 (s) 5'-TCAAACAAAGGACCAGCTGGA 
CAACATACTG-3',  (as) 5'-CTGTCTAGGTCCTGGAGTC- 
CAGCAGACTCA-3'; IFN-"/ (s) 5'-CATGAAAATCCTGCA- 
GAGCCAG-3',  (as)  5'-TGCTGGCAGAATTATTCTTAT- 
TGG-3'; TGF-]3  (s) 5'-CTCCCACTCCCGTGGCTTCTAG-3', 
(as) 5'-GTTCCACATGTTGCTCCACACTTG-3'; and TNF-el 
(s) 5'-CCACGTCGTAGCAAACCACC-3', (as) 5'-AAGTAC- 
TTGGGCAGATTGACCTC-3'. The RT-PCR products were 
electrophoresed on  1.5% agarose  (FMC BioProducts, Rockland, 
ME) gels and stained with ethidmm brmmde. 
Results 
blduction  qf Autoimmune  Disease by NTx.  Tx  on  day  3 
after birth produced, in 3 too, histologically evident gastri- 
tis  accompanying high  titers  of circulating antiparietal  cell 
autoantibodies  in "-40%  of BALB/c mice,  and  oophoritis 
with annoocyte autoannbodies m  20% of mice. Tx on day 
0 or 7 was far less efiqcient for autounmune induction (15% 
incidence of gastritis and no oophoritis), and Tx on day  14 
or adult  (6  wk  of age)  was unable  to  elicit  autolmmumty 
(Fig.  l  A).  Percent  composition  of CD3 +  cells  in  the 
lymph nodes of day 0, 3, or 7, or non-Tx mice at 3 mo of 
age was  17.1  +  2.7,  23.1  _+  1.4,  45.0  •  2.2,  69.0  --- 4.2, 
respectively  0l  =  5).  NTx  reduced  a  greater  number  of 
CD4 ~ cells than CD8 + cells: percent composition of CD4 + 
or CD8 + cells  m  the b,mph nodes of day 3 Tx nuce (n  = 
5)  was  18.5  +  7.5%  and  9.5  +  3.6%,  respectively,  com- 
pared with 44.0  +  8.7% and  13.1  ___ 0.6%, respectively, m 
sham Tx mtce (,1  =  5). 
The  time  course  study  of serological  and  histological 
development of gastric autoimmunity after day 3 Tx showed 
that significant titers  of antiparietal  cell autoantibo&es  be- 
came detectable by ELISA from 3 to 4 wk after Tx (Fig.  1 B). 
It took 5--6 wk for inflammatory destruction of the parietal 
cells to become histologically evident,  although cellular in- 
filtration  to  the  gastric  mucosa  began  earlier  (data  not 
shown).  The degree of histological severity of the  gastritis 
was  well  correlated  with  the  titers  of antiparietal  cell  au- 
toanttbo&es when Tx mice were examined at 2 mo of age. 
These  results  indicate  that  pathogenic  self reactive  T  cells 
are activated within a couple of weeks after day 3 Tx. 
Omoge~l F of CD25 + T  Cells and Effects of NTx  on the On- 
togen),.  By  flow  cytometric  analysis,  few  splenic  CD3* 
cells expressed CD25 in 3-d-old mice (0.06  +  0. l%, n =  7); 
in  contrast,  a  significant  fraction  of CD3 + cells  expressed 
CD25  m  7-d-old  (5.48  4-  0.93%,  n  =  5)  or  adult  mice 
(10.8  _+  1.01%, n =  1 l)  (Fig. 2 A). In infant as well as adult 
mice, 5-10% ofCD4 + cells  and <l%  ofCD8 § spleen cells 
expressed  CD25;  the  majonty ofCD25 + cells  dM not co- 
express  IL-2RI3 (24). We noted that  a larger fraction of B 
cells  of neonatal  mice  expressed  CD25,  compared  with 
adult  mice  (Fig.  2  A).  These  B  cells  may be  immature  B 
cells as demonstrated  for a smMar immature  population in 
the adult bone marrow (36). 
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Figure  1.  (A) Incidence ofautoimmune gasmtts m trace thymectomazed 
on vanous days after birth. BALB/c  mice received Tx on days 0  (within 
24  h  after birth),  3,  7,  or  14  Mice  were histologically  and serologlcally 
examined 3 mo after Tx, (/3) BAI_B/c lmce were thymectot1:uzed on day 3 
and  examined for h~stologlcal development of gasmns and nters of ann- 
parietal cell autoantibo&es at various ages as shown  (O) Grade 2 gasmns: 
(Q) grade  1 gasmns; and (O) intact gasmc mucosa. 
Similar  analyses  of CD25-expressing  T  cells  in  normal 
BALB/c mice at various ages revealed that CD3 + CD25 + 
cells began to appear m  the spleen immediately after day 3, 
rapidly increasing within 2 wk to adult levels in percentage 
among CD3 + cells (Fig. 2 B) and in absolute numbers (Fig. 
2 C). Other mouse strains,  such as A/J and C57BL/6 (which 
are  high-  and low-incidence  strain,  respecnvely,  of NTx- 
reduced autoimmune disease  [91), also showed ontogemc pat- 
terns of CD25 + T  cells sinular to BALB/c (data not shown). 
Tx on day 3  not only reduced the number ofCD3 + cells, 
especially CD4 + cells,  but also depleted CD3 + CD25 + cells 
for 1 wk after Tx  (Fig.  2  C).  3  mo after  NTx,  CD25 ~ T 
cells constituted  19.6  --- 2.6% (n =  5) of splenic CD4 + cells 
and 4.4 +  2.6% (n  =  5) ofCD8 § cells,  indicating that they 
might have developed from the  CD25-  T  cell population 
that  had  migrated  to  the  periphery  before  NTx  (see  also 
Fig. 4). 
Prevention  qf NTx-induced A1aoimmune  Disease  by Inoculat- 
ing CD25 + T  Cell~  fiom S)nlgeneic Normal Adult Alice.  To de- 
termine whether CD25 + CD4 + cells prevent autoimmune 
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Figure  2.  (A)  Expression  of C1)25  on  splenic  CI)3 ~ 
cells from 3-,  7-,  or 60-d-old BALB/c mice.  Cells  were 
stained  with PE-anti-CD25 (abscissa) and FITC-anti-Cl)3 
(orditlate). A  representative staining of" seven independent 
experiments  is  shown.  (B)  Percentages  of C1)25 +  cells 
among CI)3 + cells, calculated from CI)3-CI)25 staining as 
shown in A,  in spleens from mice at various  ages. (Vertical 
bars) Mean SD.  (C)  The  number of C1)3 + and C1)25" 
Cl)3 + cells in spleens of day 3 Tx or non-Tx mice at vari- 
ous  ages￿9 The  numbers  were  calculated  from  the  total 
number of spleen cells and the percentages  of each popula- 
tion  in  spleens,  as  shown  m  A.  The  number of Cl)3 + 
CD25 + cells in the spleens 1 wk after day 3 Tx was <li)  4 
per spleen (asterisk). 
development in NTx mice, graded numbers of splenic T 
cell  subpopulations  from  syngeneic  non-Tx  adult  mice 
were inoculated into NTx  mice  1 wk after NTx;  the recip- 
ients  were  histologically  and  serologically  examined  3  mo 
later (Fig. 3). CD4 +  CD25-  cell suspensions, adjusted to an 
autoimmune-preventive  dose of CD4 +  cells  (107), failed to 
prevent gastritis. On  the other hand, a small dose (2  ￿  10  ~) 
of cell  suspensions  enriched  for  CD4 +  CD25 +  cells  pre- 
vented  autoimnmnity,  but  an  equivalent  dose  of  CD4 + 
cells did not.  CD8 +  cells,  ~'-,1% of which  expressed  CD25 
(24),  were  far less effective for prevention when  compared 
with an equivalent dose  of CD4 +  cells (10v).  We  obtained 
similar  results  of CD25 +  cell-mediated  autoinmmne  pre- 
vention  on  other  NTx-induced  autoimmune  diseases  in 
other strains, e.g.,  autoimmune  oophoritis in A/J mice  (15) 
(Sakaguchi,  S.,  unpublished  data).  Taken  together,  these 
results  indicated  that  the  autoimmune-preventive  activity 
was mainly, if not solely, in the CD25 +  CD4 + population. 
To  determine  the fate  and  CD25-phenotypic  change  of 
the inoculated CD4  subpopulations (CD4 +, CD4 + CD25  , 
or  CD4 §  CD25 +  cells),  they  were  prepared  from  the 
spleens of BALB/c  Thy-1"  mice  and inoculated  into day  3 
Tx BALB/c  mice, which are  Thy- I I' (Fig. 4).  Higher num- 
bers ofCD25  +  Thy-1.1 +  T  cells (~40%  ofThy-l.1  +  cells) 
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were present 2 mo after inoculation in the NTx mice inoc- 
ulated with Thy-l.1 + CD4 + CD25 + cell-enriched suspen- 
sions (50-60% pure for CD25 + cells)  compared with those 
inoculated  with  whole  CD4 +  or  CD4 +  CD25-  cells  (in 
these  mice,  CD25 +  cells  constituted  "o10%  of Thy-l.1 + 
cells).  Thus, at least some of the inoculated CD25 + T  cells 
persisted  and  presumably proliferated  as  CD25 +.  Further- 
more,  appearance  ofCD25 + Thy-l.1 +  cells  in NTx mice 
inoculated  with  CD25-  Thy-l.1 +  cells  indicated  that  a 
fraction  of inoculated  CD25-  cells  had  differentiated  to 
CD25 + cells,  as was also suggested by the finding that NTx 
mice developed CD25 + T  cells  (Fig. 2  C). 
Induction of Autoimmune Disease in nu/nu Mice by Transfer 
of Newborn Spleen Cells or CD25 + Cell-depleted  Spleen Cells 
from  Older Mice at Any Age.  The above results indicate that 
the  peripheral  T  cell population  of 3-d-old  mice  may be 
deficient  in  autoimmune-preventive  CD25 +  T  cells  but 
may contain some self-reactive T  cells,  and mice older than 
3 d of age may bear pathogenic self-reactive T  cells and suf- 
ficient numbers of CD25 + autoimmune-preventive  T  cells 
to  control  them.  To  demonstrate  this,  we  inoculated 
splenic cell suspensions, prepared from BALB/c nu/+ mice 
at  various  ages,  into  adult  BALB/c nu/nu  mice  that were 
histologically and serologically examined 3 mo later for the 
development of autoimmune disease  (Table  1).  The nu/nu 
mice transferred with spleen cells  from 3-d-old nu/+  mice 
developed  autoimmune  diseases,  including  gastritis  and 
oophoritis, whereas those transferred with spleen cells from 
14-d  or  8-wk-old  nu/+  mice  developed  few  or  no  au- 
toimmunities.  In  contrast,  when  the  inocula  from  adult 
mice were depleted ofCD25 + cells by treatment with anti- 
CD25  and  C,  the  recipients  developed  autoimmune  dis- 
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eases.  The  spectrum  of affected  organs  and  incidences  of 
the autoimmune diseases were dependent on the dosages of 
inoculated CD25- cells. 
Inoculation of spleen cells from 3-d-old nu/+ mice into 
3-d-old nu/nu littermates  produced autoimmune disease as 
well. This indicates that the condition of T  cells  in 3-d-old 
mice  may be  critical  for autoimmune  induction,  whereas 
age-dependent differences,  if any, in the  conditions of the 
target antigens  (37),  the functions of antigen-presenting  or 
B cells  (38, 39), or other host conditions, may not. 
Furthermore,  comparable  incidences  of  autoimmune 
diseases  developed  in  nu/nu  mice whether  the  transferred 
CD25-  cells  were  prepared  from 2  or  12-mo-old  nu/+ 
mice.  Thus,  the potentially pathogenic self-reactive T  cells 
were present in the periphery of aged as well as neonatal or 
young mice;  they  were  not  significantly  deleted  (12-15, 
40),  rendered anergic  (14),  or diluted out in the periphery 
with aging (13). Moreover, elimination/reduction ofCD25 + 
T  cells  could activate the self-reactive T  ceils at any age. 
Transcription of Cytokine  Genes in Splenic CD4 + Cells  from 
Mice at Various Ages.  To  characterize  further the  autoim- 
mune-inducing or autoimmune-preventive CD4 + cells,  we 
analyzed transcription ofcytokine genes (IL-2, IL-4, IL-10, 
IFN-y,  TNF-e~,  and  TGF-]3)  in  CD4 +  cell  suspensions 
(105)  prepared  by  cytofluorometric  cell  sorting  from  the 
spleens  of 3-,  7-,  or 60-d-old BALB/c mice,  or the  same 
number  of CD4 +  CD25 +  or CD4 +  CD25-  splenic  cells 
from 60-d-old BALB/c mice. This P,T-PCP,. method with 
amplification  of cDNAs by random primers  is  sufficiently 
sensitive to detect a single lymphocyte quantity of cytokine 
mP,  NA (Toda, M., and S. Sakaguchi, manuscript in prepa- 
ration).  The analysis shown in  Fig.  5  confirmed the  result Inoculated 
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Figure  4.  Day 3 Tx BALB/c mice were inocu- 
lated with 2 ￿  10  ~' CD4 +, CD4 + CD25  , or CD4 + 
CD25 +  splenic cells prepared  from  Thy-l.1 
BALB/c congenic mice and examined 2 mo later￿9 
Lymph node  cells were  stained with  FITC-anti- 
Thy-l.1  (ordinate) and  PE-anti-CD4  or  PE-anti- 
CD25  (abscissa). A representative staining of four 
independent experiments is shown. 
of cytofluorometric study that few  CD4 +  cells of 3-d-old 
mice express CD25  (Fig. 2 A). CD4 §  cells from 3-, 7-, or 
60-d-old mice, as well as CD4 + CD25 + or CD4 + CD25 
cells from 60-d-old mice, transcribed a comparable level of 
IL-2, IFN-'y, or TNF-o~ gene.  In contrast,  IL-4, IL-10, or 
TGF-[3 transcripts were  predominantly detected in CD4 + 
cells  from  7-d-old  or  adult  mice,  especially  in  CD25 + 
CD4 + cells, compared with CD4 + cells from 3-d-old mice 
or CD25-  CD4 +  cells from  adults.  Thus,  the  CD4 +  cells 
of 3-d-old  mice  were  similar  to  CD25-  CD4 +  cells  of 
adult mice not only in the nonexpression of CD25  mole- 
cules but also in their cytokine profile; the CD25 +  CD4 + 
population, which began to appear in the periphery imme- 
diately after day 3,  predominantly contained cells forming 
IL-4, IL-10, and/or TGF-13. 
Discussion 
The main conclusion from the data in this report is that 
one  aspect  of peripheral  self-tolerance  is  maintained  by 
CD25 + T  cells that sustain potentially pathogenic self-reac- 
tive T  cells in a CD25-  dormant state. The ontogenic time 
course of the former is intrinsically programmed as the de- 
velopmental  process  in  normal  mice  and  abnormality  in 
this  process  can  cause  autoimmune  disease  in  genetically 
susceptible individuals. 
We showed that CD25 + T  cells ontogenically began to 
appear in  the  periphery of normal  mice  from  day 3  after 
birth.  Hence,  Tx  on  day  3  transiently  depleted/reduced 
CD25 + T  cells from the periphery, inoculation of CD25 + 
T  cells from  non-Tx  mice  effectively prevented  autoim- 
mune  development,  and  transfer of CD25-  T  cells from 
3-d-old  or  older  nu/+  mice  successfully induced  similar 
autoimmune disease in nu/nu  mice. These results, taken to- 
gether, indicate the following: (a)  the thymus of an appar- 
ently  nonautoimmune  strain  of mice  (such  as  BALB/c) 
produces  not  only  potentially pathogenic  self-reactive T 
cells  (which  persist in  the  normal  periphery  at  a  CD25- 
dormant state) but also CD25 + T  cells capable ofdownreg- 
ulating  the  activation/expansion  of  self-reactive  T  cells 
392  Developmental Control of Self-reactive T Cells Table 1.  Induction of  Autoimmune  Disease in BALB/c nu/nu Mice by Inoculating T Cells  from BALB/c nu/+ mice at Various Ages 
No. of mice with autoimmune disease 
Exp.  Age of  No. of cells  Treatment 
group  donors  treated  of cells  No. of mice  Gastritis  Oophoritis  Thyroiditis 
A  3 d  1-2 X 107  -  7*  3 (42.9)  1 (14.3)  0 
B  3 d  3 X 107  --  12  6 (50.0)  5 (41.7)  0 
C  14 d  3 ￿  107  Anti-CD25 +  C  8  8 (100)  5 (62.5)  0 
D  14 d  3 X 10  v  C  8  1 (12.5)  0  0 
E  8 wk  3 ￿  10  v  Anti-CD25 +  C  8  8 (100)  6 (75.0)  3 
F  8 wk  3 ￿  10  v  C  12  0  0  0 
G  8 wk  2 X 106  Anti-CD25 +  C  8  4 (50.0)  2 (25.0)  0 
H  8 wk  2 ￿  106  C  8  0  0  0 
I  1 yr  3 ￿  107  Anti-CD25 +  C  8  7 (87.5)  4 (50.0)  0 
(37.5) 
Indicated numbers of spleen cells from 3-d-old female BALB/c nu/+ or +/+ mice  were inoculated into 3-d-old littermate nu/nu mice (*) (group 
A) or 6-wk-old BALB/c nu/nu mice (group /3). In groups C-I, indicated numbers of spleen cells from nu/+ or +/+ mice at various ages were 
treated with anti-CD25 and complement (C), or C alone, and then inoculated into 6-wk-old female BALB/c nu/nu mice. The recipient nu/nu mice 
were histologically  examined 2 mo later. Number of mice bearing respective autoimmune diseases (with histological  severity of grade 1 and 2, see 
Materials and Methods and references 20, 24) is shown with percent incidence in parentheses. Note that CD25- cell suspensions  prepared from 2 X 
106 adult nu/+ spleen cells (group G) and from 3 X 107 3-d-old nu/+ spleen cells (group B) contained an equivalent number ofCD25- T cells (see 
Fig. 2 A). 
Figure 5.  Transcriptions  of various cytokine mRNAs were assessed by 
RT-PCR with the same number (10  s) of CD4 § cells sorted by FACS  | 
from spleens of 3-, 7-,  or 60-d-old BALB/c mice. CD4  + CD25  + or 
CD4  + CD25  + spleen cells (105) prepared from 60-d-old BALB/c mice 
by FACS  |  were also examined. 
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from the CD25-  dormant state;  (b) the production of the 
former begins before day 3, whereas production of the lat- 
ter immediately after day 3; hence, (c)  NTx on day 3  may 
abrogate,  at  least  transiently,  the  CD25 +  cell-mediated 
control on the self-reactive T  cells that have been produced 
before day 3, allowing some of them to become activated, 
expand,  and  eventually cause  chnically and  histologically 
evident autoimmune diseases.  Judging from the  rapid in- 
crease  of CD25 +  T  cells from  day  3  on,  it  is  likely that 
mice at 7 d of age have already harbored sufficient numbers 
of CD25 +  regulatory cells to  control CD25-  self-reactive 
T  cells; on the other hand, 0-d-old mice, as deficient of the 
CD25 +  population as  3-d-old  mice,  bear  much  smaller 
numbers of CD25- self-reactive T  cells than 3-d-old mice. 
Hence, both day 0 and day 7 Tx are far less efficient for au- 
toimmune induction than day 3 Tx. 
One may argue, however, that a quantitative change of 
T  cell number in ontogeny, not a  qualitative change of T 
cell  subpopulations, may  be  responsible for  autoimmune 
development after NTx. For example, a T-lymphocytope- 
nia due to NTx might incur viral infection and the result- 
ant activation of antigen-presenting  cells might lead to acti- 
vation of self-reactive T  cells (19).  This does not seem to 
be  the  case  for  the  following reasons.  First,  a  deliberate 
preparation of T-lymphocytopenia in nu/nu mice by inoc- 
ulating a small number (e.g., 2  ￿  106) ofnu/+  spleen cells 
failed  to  produce  autoimmune  disease,  whereas  a  large 
number of CD25-  nu/+  T  cells (e.g., prepared from 3  ￿ 
107 spleen cells)  effectively produced autoimmune disease. 
Second, transplantation  of nu/+ newborn thymuses in nu/nu 
mice produced similar autoimmune diseases without T-lym- 
phocytopenia (41). Third, others have shown that mainte- nance  of germ-free  NTx  mice  in  germ-flee  conditions 
could not prevent autoimmune development (42). 
The autoimmune-preventive CD25 + CD4 + cells in nor- 
real  unimmunized  mice  were  apparently  indistinguishable 
from "activated," "memory," or "effector" T  cells not only 
in their expression patterns of various cell surface molecules 
(including  CD45RB  and CD5  [24]) but also cytokine for- 
mation (Fig. 5)  (43-45).  Indeed, the CD25-  T  cell popula- 
tion gave rise to CD25 + activated,  effector T  cells (24, and 
Fig.  4).  Furthermore,  polyclonal  CD25 +  activated  T  cell 
blasts prepared by mitogen stimulation of normal T  cells ef- 
fectively  prevented  NTx-induced  autoimmune  disease 
(Sakaguchi,  S.,  unpublished  data).  Although  it  remains  to 
be  determined  whether  any  T  cells  acquire  the  autoim- 
mune-preventive  activity  upon  activation,  these  findings 
suggest that the ontogenic  time course and the basal num- 
ber of the autoimmune-preventive  CD25 + population may 
be developmentally programmed, but the size of the popu- 
lation may not be innately fixed and may increase when T 
cells are activated in immune responses to non-self antigens 
(24).  To elucidate further the mechanism of this CD25 + T 
cell-mediated  control,  it  is  currently  under  investigation 
whether  cytokines,  such  as  IL-4,  IL-10,  or  TGF-[3,  pre- 
dominantly produced by CD25 + CD4 + T  cells (Fig. 5), are 
responsible for sustaining self-reactive T  cells in the CD25- 
dormant state. 
The  CD25 +  T  cell-mediated  immunoregulation  is  the 
key, but not the sole, mechanism of controlling pathogenic 
self-reactive  T  cells.  Indeed,  others  have  shown  that  in- 
trathymic expression of the gastric parietal cell antigens in- 
hibited  NTx-induced  gastritis  (46,  47).  Given the fact that 
T  cells  bearing  high  affinity  TCRs  for  intrathymic  self- 
antigens or peripheral organ~specific antigens circulating to 
the thymus can be clonally deleted  (even at a much lower 
antigen  concentration  than  that  required  for  activation 
[48]),  it  is  likely  that  potentially  pathogenic  self-reactive 
T  cells  that  have  escaped  the  thymic-negative  selection, 
may bear low affinity TCRs  for the  relevant self-antigens, 
hence  high  thresholds  for activation.  The  CD25 +  T  cell- 
derived suppressive signal may further raise the  thresholds, 
thereby  stably  maintaining  them  in  the  CD25-  dormant 
state  even when  they recognize  self-peptides presented  by 
antigen-presenting  cells  (49).  By contrast,  some,  if not  all, 
T  cells specific for non-self antigens may easily overwhelm 
the suppression  and become activated upon antigen  stinm- 
lation  presumably because  of their  high  affinity TCtLs  for 
the  antigens,  and  hence,  low  activation  thresholds,  even 
though  the  CD25 +  T  cell-derived  suppressive  signal  may 
raise the thresholds to the same extent as for self-reactive T 
cells.  The  T  cell-mediated  peripheral  immunoregulation 
and the thymic clonal deletion may thus cooperatively sus- 
tain  stable  self-tolerance  while  enabling  effective imnmne 
responses to non-self antigens. 
The  present  findings  in  mice  may  also  apply  to  other 
species and other autoimmune diseases.  For example, NTx 
causes  or  aggravates  thyroiditis  in  chickens  (50)  and  rats 
(51).  Furthermore,  spontaneous autoimmune diseases (e.g., 
diabetes mellitus and thyroiditis  in NOD  mice or BB rats) 
can be prevented by inoculating  CD4 + cells from the  his- 
tocompatible  nomlal  animals  before  clinical  onset  of au- 
toimmune  disease  (52,  53).  The  autoimmune-preventive 
CD4 +  T  ceils in  these  models  might  be  CD25 +,  and  the 
models  might  have  genetically  determined  abnormality  in 
the  CD25 +  cell-mediated  control  of self-reactive  T  cells. 
Further  molecular  analysis  of the  autoimmune-preventive 
activity  of CD25 +  T  cells  and  search  for  environmental 
agents  or genetical  abnormalities  reducing  CD25 + T  cells, 
retarding  their  ontogeny,  or  affecting  their  autoimmune- 
preventive activity, would contribute  to our understanding 
of the  etiology  and  pathogenetic  mechanism  of autoim- 
mune disease. 
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